Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate steady-state pharmacokinetics of DTG dispersible
tablets in children with HIV infection weighing from 6 to below 20 kg and to determine the
dose of DTG that achieves adult target PK parameter(trough concentration; AUC24h)